Express Scripts (ESRX) Upgraded at TheStreet
Express Scripts (NASDAQ:ESRX) was upgraded by equities researchers at TheStreet from a “c+” rating to a “b-” rating in a report released on Monday.
Several other analysts have also weighed in on ESRX. Morgan Stanley boosted their price objective on Express Scripts from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Jefferies Group set a $72.00 price objective on Express Scripts and gave the company a “buy” rating in a report on Tuesday, August 29th. Robert W. Baird reissued a “hold” rating and issued a $56.00 price objective on shares of Express Scripts in a report on Friday, September 1st. ValuEngine lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Royal Bank Of Canada started coverage on Express Scripts in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price objective for the company. Six equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $70.67.
Shares of Express Scripts (NASDAQ ESRX) traded up $0.73 during trading on Monday, reaching $68.57. The company had a trading volume of 3,737,241 shares, compared to its average volume of 4,119,528. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market capitalization of $38,603.98, a price-to-earnings ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88. Express Scripts has a 1 year low of $55.80 and a 1 year high of $76.38.
In other Express Scripts news, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares in the company, valued at $735,195. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of Express Scripts stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Dodge & Cox boosted its position in shares of Express Scripts by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after buying an additional 7,388,021 shares during the period. Macquarie Group Ltd. boosted its position in shares of Express Scripts by 8.4% during the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after buying an additional 922,406 shares during the period. Northern Trust Corp boosted its position in shares of Express Scripts by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after buying an additional 1,206,980 shares during the period. Veritas Asset Management LLP boosted its position in shares of Express Scripts by 5.6% during the third quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock worth $547,902,000 after buying an additional 460,338 shares during the period. Finally, Nordea Investment Management AB boosted its position in shares of Express Scripts by 2.6% during the third quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock worth $462,551,000 after buying an additional 188,528 shares during the period. Institutional investors and hedge funds own 88.44% of the company’s stock.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.